Vivira Health Lab develops and markets evidence-based digital health applications to help people with musculoskeletal disorders reduce pain and restore physical function. The company’s mission is to make guideline-based therapeutic training widely accessible through clinically validated digital programs.

Vivira focuses on medical effectiveness, patient safety, data protection and information security. The company operates from offices in Munich and Berlin and was founded in 2015 by Dr. Philip Heimann, Dr. Petra Becker and Fabian Blank.

Its flagship product, the ViViRA app, delivers guided therapeutic training for home use to treat acute and chronic back pain. ViViRA is a CE-marked medical device (Class I) and is permanently listed by the German Federal Institute for Drugs and Medical Devices (BfArM) as a reimbursable Digital Health Application (DiGA).

The app is reimbursable with a physician’s prescription for statutory health insurance in Germany; private and other reimbursement options may apply. More than 200,000 people have used ViViRA.

Vivira Health Lab holds ISO 27001 (information security) and ISO 13485 (medical device quality) certifications and processes user data within Germany and the EU in compliance with GDPR. Customer support is available by phone at 030 814 53 6868 and by email at [email protected]. Career opportunities and a prescription service are listed on the company website.